Saturday 17 October 2026 Export ATRA’s income statement to Excel — free account

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.8 million, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue fell 96.4%, EPS fell 260.0% and free cash flow grew 52.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

9.18 0.47 −4.87%

Follow ATRA

Alert me

Market cap: $96.9M
P/E: 0.0×
Fwd P/E: −8.4×
Dividend yield: —
F-score: 5/9
Altman Z: −125.91
Beneish M: 16.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	3	3
ROE Full definition →		(36.80%)	(48.15%)	20.49%	46.33%
ROA Full definition →		27.07%	50.55%	(23.08%)	(57.62%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		4,482.95%	(1,239.59%)	(143.81%)	(248.19%)
Average Days of Receivables Full definition →		4.60	3.79	0.00	18.74
Free Cash Flow per Share Full definition →		(5.12)	(3.99)	(1.84)	(1.46)
Free Cash Flow Full definition →		(69.41)	(50.08)	(25.87)	(21.89)
Capital Expenditures Full definition →		0.30	0.86	—	—
Other line items
Cash ROIC Full definition →		302.81%	166.83%	89.37%	80.72%
Accounts Receivable Turnover Full definition →		70.09	93.33	0.00	6.88
Accounts Payable Turnover Full definition →		22.65	9.44	0.89	0.41
Inventory Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		4.16	2.19	259.20	563.22
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		43.70%	31.00%	43.98%	67.99%
Selling, General and Administrative Expense of Revenue Full definition →		20.68%	21.74%	79.41%	253.07%
Share Based Compensation of Revenue Full definition →		9.27%	8.07%	27.19%	62.72%
Interest Coverage Full definition →		6.70	9.46	(1.75)	(5.04)
Operating CF/Net income Full definition →		(2.98)	(1.56)	2.73	1.31
Depreciation/Fixed assets Full definition →		21.31	32.53	6.36	2.44
Capex/Depreciation Full definition →		0.10	0.36	0.00	0.00
Revenue per Share Full definition →		11.20	9.63	1.64	0.41
Operating CF per Share Full definition →		(5.14)	(4.06)	(1.84)	(1.46)
Capex per Share Full definition →		0.02	0.07	0.00	0.00
Capex to Sales Full definition →		0.00	(0.01)	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly